For islet transplantation, maintaining organ viability after pancreas procurement is critically important for optimal graft function and survival. We recently reported that islet yield was significantly higher in the modified ET-Kyoto (MK) solution, which includes a trypsin inhibitor (ulinastatin), compared with the UW solution, and that the advantages of MK solution are trypsin inhibition and less collagenase inhibition. In this study, we compared ulinastatin with other trypsin inhibitors, gabexate mesilate, and nafamostat mesilate, in preservation solution for islet isolation. Ulinastatin was easily dissolved in ET-Kyoto solution, while ET-Kyoto with gabexate mesilate and nafamostat mesilate became cloudy immediately after addition. Although there were no significant differences in islet yield among the three groups, viability was significantly higher for the MK group than for the GK group or the NK group. The stimulation index was significantly higher for the MK group than for the GK group. In summary, there are no other trypsin inhibitors that are more effective than ulinastatin. Based on these data, we now use ET-Kyoto solution with ulinastatin for clinical islet transplantation.
INTRODUCTION
disadvantages: it is chemically unstable, it must be cold stored until use, and its short shelf life makes it expensive. It is also highly viscous, which may complicate The solution for organ preservation is critically important for maintaining its function, reducing ische-the initial organ flush (30). Extracellular-type trehalosecontaining Kyoto (ET-Kyoto) solution was recently mia-reperfusion injury, and, therefore, increasing transplant efficiency. For islet transplantation, the storage developed for organ preservation solution and its effectiveness in cold lung storage has been demonstrated in conditions of the donor pancreas may influence the deleterious consequences of isolated islets during transplan-clinical lung transplantation (4, 23) . It also is effective for skin flap storage and its clinical application is begin-tation, which remains a major source of current issues in clinical practice. Donor pancreata for islet transplan-ning in this field (31). We previously showed that pancreas preservation tation are usually preserved with University of Wisconsin (UW) solution. However, UW solution has several with modified ET-Kyoto (MK) solution significantly 510 NOGUCHI ET AL.
improved islet yields, compared with UW preservation Porcine Islet Isolation (21) . Although high potassium in UW solution causes Porcine pancreata were obtained at a local slaughterinsulin release from pancreatic β-cells (6) , ET-Kyoto house. About 10 min after the cessation of heart beating, solution has a high sodium/low potassium composition.
the operation was started. After removing the pancreas, Moreover, UW solution inhibits the activity of collagenwe immediately inserted a cannula into the main pancrease, an enzyme blend for pancreatic digestion (5, 27) , but atic duct, infused each preservation solution for ductal MK solution inhibits collagenase to a lesser extent (21) .
protection (9, 20) , and put the pancreas into each two-MK solution includes a trypsin inhibitor (ulinastatin), layer [preservation solution/perfluorochemical (PFC)] which is one of the advantages of this solution. Indeed, preservation container. Operation time was defined as pancreas preservation using MK solution was superior the time elapsed between the start of operation and to that using ET-Kyoto solution without the trypsin removal of the pancreas. Warm ischemic time (WIT) inhibitor in a rat model (21) .
was defined as the time elapsed between cessation of In this study, we compared ulinastatin with other heart beating and placement of the pancreas into the trypsin inhibitors (gabexate mesilate, and nafamostat preservation solution. Cold ischemic time (CIT) was mesilate) in preservation solution for islet isolation. defined as the time elapsed between placement of the pancreas into the preservation solution and the start of MATERIALS AND METHODS islet isolation.
Preservation Solution
Islet isolation was conducted as previously described (9, 10, 15, 22) in the standard Ricordi technique (26) with We used ET-Kyoto solution (4,23) with ulinastatin modifications introduced in the Edmonton protocol (Miraclid, Mochida Pharmaceutical, Tokyo, Japan; (11, 24, 28) . In brief, after decontamination of the pannamed MK solution), gabexate mesilate (FOY, Ono creas, the ducts were perfused in a controlled fashion Pharmaceutical, Osaka, Japan; named GK solution), and with a cold enzyme blend of Liberase HI (1.4 mg/ml; nafamostat mesilate (FUTHAN, Torii Pharmaceutical, Roche Molecular Biochemicals, Indianapolis, IN). The Tokyo, Japan; named NK solution). The components of distended pancreas was then cut into 7-9 pieces, placed the solutions are shown in Table 1. in a Ricordi chamber, and shaken gently. While the pan-Measurement of Trypsin Inhibition Ability of Solutions creas was being digested by recirculating the enzyme solution through the Ricordi chamber at 37°C, we moni-In order to assess the trypsin inhibition of MK, GK, tored the extent of digestion with dithizone staining by and NK solutions and ET-Kyoto solution without tryptaking small samples from the system. Once digestion sin inhibitors (control), 3 ml of 0.3 mM N-benzoyl-Lwas confirmed to be complete, RPMI-1640 medium arginine ethylester reagent (BAEE; Sigma, Tokyo, (Gibco, Carlsbad, CA) was introduced into the system. Japan) was incubated for 5 min at 25°C and then 5 µl
Then the system was cooled to stop further digestive of 1 mg/ml trypsin and 45 µl of each solution were activity. The digested tissue was collected and washed added. Trypsin activity was measured by absorption with fresh medium to remove the enzyme. The phase I spectrophotometry (λ253 nm) using BAEE for the trypperiod was defined as the time between placement of the sin substrate, according to a previous report (12) . Absorpancreas in the Ricordi chamber and the start of collecting bance was measured at every minute up to 6 min. A the digested pancreas. The phase II period was defined as BAEE unit was defined as a change in optical density the time between the start and end of collection. of 0.001/min. Islets were purified with a continuous density gradient with iodixanol (Optiprep, Sigma-Aldrich, St. Louis, MO)-Kyoto (IK) solution in an apheresis system (COBE Louis, MO) using an optical graticule. The crude num-Systems GmbH, Pforzheim, Germany) and expressed as the number of relative light units (RLU). After 10 min, ber of islets was then converted to the standard number of islet equivalents (IEQ; diameter standardizing to 150 the ADP in the solution was converted to ATP by adding 20 µl ADP converting reagent and then measured as µm) (25). Gross morphology was qualitatively assessed by two independent investigators scoring the islets for the number of RLU. Subsequently, the ADP/ATP ratio of the islets was calculated. shape (flat vs. spherical), border (irregular vs. wellrounded), integrity (fragmented vs. solid/compact), uni-In Vivo Assessment of Islet Function formity of staining (not uniform vs. perfectly uniform), and diameter (least desirable: all cells <100 µm/most Severe combined immunodeficient mice (SCID; CLEA desirable: more than 10% of the cells >200 µm) (11, 25) .
Japan, Inc., Meguro, Tokyo) were used for the experi-Each parameter was graded from zero to 2 with zero ments. The recipients were rendered diabetic by a single equaling the worst and 2 the best score, so that the worst injection of streptozotocin (STZ) at a dose of 220 mg/ islet preparations were given a cumulative score of zero kg. Hyperglycemia was defined as a glucose level of and the best a score of 10. Spherical, well-rounded, >350 mg/dl detected twice consecutively after STZ solid/compact, uniformly stained, and large islets were injection. The 2,000 IEQ pig islets obtained from each characterized as the best islets.
group were transplanted into the renal subcapsular space Islet viability after purification was assessed using acriof the left kidney of a diabetic SCID mice as previously dine orange (10 µmol/L) and propidium iodide (15 µmol/ described (16, 17, 20) . During the 30-day posttransplanta-L) (AO/PI) staining to visualize living and dead islet cells tion period, the nonfasting blood glucose levels were simultaneously (3,11,25). Fifty islets were inspected and monitored three times per week. Normoglycemia was their individual viability was determined visually, foldefined when two consecutive blood glucose level mealowed by calculation of their average viability (11) .
surements showed less than 200 mg/dl. No statistical differences in either pretransplantation blood glucose In Vitro Assessment of Islet Function levels or pretransplantation body weight were observed Islet function was assessed by monitoring the insulin among the three groups of mice. Mouse studies were secretory response of the purified islets during glucose approved by the Institutional Animal Research Commitstimulation according to a procedure described by Shapiro tees of Kyoto University and Fujita Health University. and colleagues (28). Briefly, 1,200 IEQ were incubated with either 2.8 or 25 mM glucose in RPMI-1640 for 2 Statistics h at 37°C and 5% CO 2 . The supernatant was collected
The differences between each group were considered and insulin levels were determined using a commercially significant if the value was p < 0.05 using an unpaired available enzyme-linked immunosorbent assay (ELISA) Student's t-test with Bonferroni correction or the kit (ALPCO Insulin ELISA kit; ALPCO Diagnostics, Kaplan-Meier log-rank test. Windham, NH). The stimulation index was calculated by determining the ratio of insulin released from islets RESULTS in high glucose concentration to the insulin released in Dissolution of Trypsin Inhibitors in ET-Kyoto Solution a low concentration. The data were normalized by total Ulinastatin, gabexate mesilate, and nafamostat mesiproteins from the cell lysate. All assessments were late were used in this study. When these trypsin inhibimade in triplicate and the data (mean ± SE) were tors were added in ET-Kyoto solution, ulinastatin was expressed as a percentage of the control values in each easily dissolved in ET-Kyoto solution, while ET-Kyoto experiment to eliminate variables caused by differences with gabexate mesilate and nafamostat mesilate became among donor pancreata.
cloudy immediately after addition (Fig. 1A) . After 30 Recently, Goto et al. showed that the measurement min, gabexate mesilate and nafamostat mesilate were of the adenosine diphosphate/adenosine triphosphate dissolved in ET-Kyoto solution. (ADP/ATP) ratio correlated with transplantation outcome (7) . The ADP/ATP ratio was measured to evaluate Inhibition of Trypsin Activity the energy status of cultured islets, using the ApoGlow TM kit (Cambrex Bio Science Nottingham Ltd., Notting-Previous reports show that trypsin inhibition with TLM preservation improves islet yields (12, 21) . We examined ham, UK). In brief, 80 IEQ of islets were washed in PBS and then mixed with 100 µl of nucleotide releasing whether MK, GK, and NK solutions inhibited trypsin activity. All three solutions significantly inhibited trypsin reagent for 10 min at room temperature. Thereafter, 20 µl of nucleotide monitoring reagent was added to the activity (Fig. 1B) , compared with ET-Kyoto (control). These observations suggest that these solutions could solution, and the ATP levels were measured using a luminometer (FB 12 Luminometer, Berthold Detection reduce trypsin activity during pancreas preservation. Porcine Islet Isolation Characteristics among the three groups. Phase I and phase II periods were also similar for the three groups. Islet yield before purification was higher, but not sig-The characteristics of porcine islet isolation protocols are shown in Table 2 . There were no significant differ-nificantly so, in the MK group (n = 9), compared with the GK group (n = 3) or NK group (n = 3) (MK: 9063 ± ences in pancreas size, operation time, WIT, or CIT 640 IEQ/g, GK: 8378 ± 642 IEQ/g, NK: 6058 ± 2116 islets under the kidney capsule of all SCID mice 30 days after transplantation. The islet grafts of each group in IEQ/g) ( Fig. 2A) . Islet yield after purification was higher, but not significantly so, in the MK group, com-the normoglycemic mice showed intense insulin staining (data not shown). pared with the NK group. There were no significant differences between the MK group and the GK group (MK:
In summary, there are no other trypsin inhibitors more effective than ulinastatin. 6864 ± 727 IEQ/g, GK: 6967 ± 439 IEQ/g, NK: 5645 ± 2268 IEQ/g) (Fig. 2B) . Other porcine islet characteris-DISCUSSION tics are shown in Table 2 . Viability was significantly higher for the MK group than for the GK group or the In this study, we showed that MK solution was superior to GK or NK solutions, although the trypsin inhibi-NK group (p < 0.01). The stimulation index was significantly higher for the MK group than for the GK group tion is greater in GK and NK than in MK. It may be due to differences of inhibitory effects of cytokines. Ulinas-(p < 0.025). There were no other significantly different characteristics among each group.
tatin has been shown to inhibit not only trypsin activity but also the release of neutrophil elastase. It also down-Assessment of Islet Function In Vitro and In Vivo regulates transcription of TNF mRNA, the activation of endothelial cells, and the expression of ICAM-1 induced To assess the islet graft function of each group in vitro, the ADP/ATP ratio was measured. There was no by endotoxin in vitro (1,2,13). It has been shown that administration of ulinastatin decreased the ischemia-significant difference in ADP/ATP ratio between each group (data not shown). To assess the islet graft function reperfusion injury (29) or attenuated the elevation in the concentrations of inflammatory cytokines and C-reactive of each group in vivo, 2,000 IEQ islets of each group were then transplanted below the kidney capsule of protein, a marker of inflammation (32) in transplanted small intestine. The superiority of ulinastatin may also STZ-induced diabetic SCID mice. The blood glucose levels of 8 of the 10 mice (80.0%) receiving islets of the be due to less collagenase inhibition than other trypsin inhibitors. We previously reported that MK solution was MK group, 7 of the 9 mice (77.8%) of the GK group, and 7 of the 10 mice (70.0%) of the NK group decreased superior to modified Celsior solution (Celsior solution with hydroxyethyl starch and nafamostat mesilate; gradually and reached normoglycemia. There was no significant difference between the groups with respect HNC). HNC solution including nafamostat mesilate inhibited collagenase activity (18) . Although different to the attainability of posttransplantation normoglycemia (Fig. 3) . Morphologic studies showed the presence of preservation solutions were used in the report, it seems that collagenase inhibition by nafamostat mesilate is brain-dead donor pancreata in US and non-heart-beating donor pancreata in Japan. MK preservation makes it fea-higher than ulinasatatin.
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